Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03453541 · ClinicalTrials.gov registry record · Phase 4
Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
A Phase 4 study, sponsored by Albany Medical College.
- Terminated
- Registry status
- Phase 4
- Development phase
- 214
- Enrollment target
NCT03453541 is a Phase 4 study that was terminated before completion, run by Albany Medical College. The registered enrollment target is 214 participants.
The verdict
NCT03453541, a Phase 4 study, was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 214 participants
- Enrollment target
Study Summary
This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.
Interventions
- DRUG Ketorolac Tromethamine
- DRUG 0.9% Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2022-11-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03453541
The ClinicalTrials.gov registry entry for NCT03453541 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac Tromethamine is the first listed.
NCT03453541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03453541 about?
NCT03453541 is a clinical study titled "Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy". This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.
What is the current status of trial NCT03453541?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 214 participants. The study started on 2017-11-21. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03453541?
The interventions under investigation include: Ketorolac Tromethamine (DRUG), 0.9% Normal Saline (DRUG).
Who is sponsoring clinical trial NCT03453541?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.